Nobody Actually Knows How Many Nigerian Children Have Autism. A New Grant Wants to Fix That.

Search “autism in Nigeria” and you’ll find plenty of parenting forums, grief, and guesswork — and comparatively little hard data. That’s not an accident. It’s the direct result of a research gap researchers themselves openly acknowledge: Africa has remarkably few studies on autism spectrum disorder (ASD) in children, and almost no consistent methodology across the ones that do exist.

The Data Nigeria Doesn’t Have
Clinic-based studies estimate autism prevalence in Nigeria at somewhere between 0.8% and 1.2% — which, applied to Nigeria’s child population, suggests well over 600,000 Nigerian children are on the spectrum, with the true number likely higher given chronic underdiagnosis tied to stigma and limited screening access. A recent systematic review pooling studies from Nigeria, Egypt, Kenya, and Uganda found reported prevalence ranging wildly from 0.54% to 23.8% depending on the study — a gap that reflects inconsistent measurement, not real underlying difference. The consequence shows up in national policy: Nigeria’s entire 2025 federal budget contained just one autism-specific allocation, ₦20 million for a single public awareness initiative.

What UNIMED Just Secured
Against that backdrop, the University of Medical Sciences (UNIMED) in Ondo State has been awarded a $45,000 grant from the Simons Foundation, a US-based organisation that funds basic science and autism research. The three-year grant will fund the Simons Academy for Neuroscience of Autism in Africa (SANAA), an intensive training programme designed to build experimental and translational autism research capacity on the continent. The initiative is being run by UNIMED’s Laboratory for Experimental and Translational Neurobiology (LETNeu), in partnership with the Cognitive Neurophysiology Lab at Albert Einstein College of Medicine in the United States.

What SANAA Is Actually Trying to Build
The programme’s core goal isn’t a single study — it’s a pipeline. SANAA is designed to bring together researchers and early-career scientists for training, mentorship, and knowledge exchange, specifically aimed at producing evidence “that reflects African populations and realities,” according to UNIMED’s public statement on the grant. That distinction matters: most autism diagnostic tools and prevalence benchmarks in wide use today were developed and validated on Western populations, and applying them uncritically elsewhere risks both over- and under-counting cases shaped by different cultural expressions of symptoms, family reporting patterns, and access to diagnosis in the first place.

UNIMED Vice-Chancellor Prof. Ebunoluwa Adejuyigbe framed the stakes plainly: “Autism remains an important area of public health and scientific inquiry,” and she said Africa needs a stronger research ecosystem capable of generating its own evidence rather than relying entirely on imported data.

Why This Matters Beyond One University
A $45,000 grant won’t single-handedly close a continental data gap. But research capacity — training the people who will eventually run the larger studies — is precisely the bottleneck experts have flagged as the reason Africa’s autism data remains so thin in the first place. Every additional trained researcher is a small step toward numbers Nigerian policymakers could actually build a budget around.

What You Can Do
• If you’re a parent with concerns about a child’s development, don’t wait for perfect national data to seek an evaluation — early screening and intervention matter regardless of how complete the surrounding research is.
• Push back on stigma in your own community. Underdiagnosis tied to shame is a documented, specific driver of Nigeria’s data gap, not just a research problem.
• Support or follow local autism research and advocacy groups — capacity-building efforts like SANAA depend on visibility and continued funding attention to scale beyond pilot programmes.